Introgen Therapeutics, Inc. (INGN)

52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:

Articles on Introgen Therapeutics, Inc. (INGN)
16 articles

Filter by:
Latest Articles Most commented on articles
Most frequent authors on INGN
  1. Alan Brochstein(5)
  2. Centient Biotech Investor(2)
  3. Charles Atan(2)
  4. ChinaBio Today(1)
  5. Mike Havrilla(1)
Most popular authors
(tracked in watchlists)
Most commented on authors
  1. Alan Brochstein(8)
  2. The Biotech Onion (6)
  3. Centient Biotech Investor(0)
  4. PharmaTracker (0)
  5. Kevin McNamara(0)